SCHEMBL30103022

SCHEMBL30103022

COC(=O)c1cc(Cl)cc2cnn(Cc3ccc(-c4ccc(F)c(OC)c4)nc3)c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 7/20 0.41
AVPR1B P47901 2/20 0.39
GRIN2B Q13224 2/20 0.38
GRIN1 Q05586 1/20 0.38
KDM1A O60341 1/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
GRM2 Q14416 1/20 0.37
BRD4 O60885 1/20 0.37
CNR1 P21554 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
TNIK Q9UKE5 1/20 0.36
ROCK2 O75116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30103083 0.94 BRD4 (0.41) CACNA1HMEN1KMT2AGRM2BRD4
SCHEMBL30103066 0.92 CACNA1H (0.40) CACNA1HAVPR1BGRIN2BGRIN1KDM1A
SCHEMBL24785079 0.90 CACNA1H (0.40) CACNA1HAVPR1BGRIN2BGRIN1BRD4
SCHEMBL30018338 0.90 CACNA1H (0.40) CACNA1HAVPR1BGRIN2BGRIN1BRD4
SCHEMBL24785835 0.88 CACNA1H (0.38) CACNA1HGRIN2BGRIN1KDM1ATNIK
SCHEMBL30103113 0.88 CACNA1H (0.38) CACNA1HGRIN2BGRIN1KDM1ATNIK
SCHEMBL24785847 0.86 BRD4 (0.40) CACNA1HMEN1KMT2AGRM2BRD4
SCHEMBL30103081 0.86 BRD4 (0.40) CACNA1HMEN1KMT2AGRM2BRD4
SCHEMBL24785849 0.86 BRD4 (0.42) CACNA1HGRM2BRD4CNR1ROCK2
SCHEMBL24784529 0.86 KMT2A (0.45) MEN1POLBKMT2AGRM2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 CN disclosed